Global Nausea And Vomiting Treatment Market Size, Status and Forecast 2020-2026

Nausea and Vomiting Treatment also called Antiemetics. Antiemetics included aprepitant, diphenhydramine, granisetron, hydroxyzine, meclizine, ondansetron, prochlorperazine, promethazine, scopolamine, metoclopramide, trimethobenzamide, palonosetron, dolasetron, and thiethylperazine, etc.
Merck & Co. Inc. was the global greatest company in Nausea And Vomiting Treatment industry, with the market Share of 14% in the 2018, followed by Helsinn Group, Unimed Pharmaceuticals (AbbVie Inc.), Kyowa Kirin, Sanofi, Qilu Pharma, Teva Pharmaceutical Industries Ltd., Taiji group, Novartis, Heron Therapeutics, Atnahs Pharma UK Limited, Mylan, Duchesnay, Tesaro.
Market Analysis and Insights: Global Nausea And Vomiting Treatment Market
In 2019, the global Nausea And Vomiting Treatment market size was US$ 4619.4 million and it is expected to reach US$ 7213.5 million by the end of 2026, with a CAGR of 6.5% during 2021-2026.
Global Nausea And Vomiting Treatment Scope and Market Size
Nausea And Vomiting Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Nausea And Vomiting Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Nausea And Vomiting Treatment market is segmented into Serotonin Receptor Antagonist, Neurokinin NK1 Receptor Antagonist, Other, etc.
Segment by Application, the Nausea And Vomiting Treatment market is segmented into CINV, PONV, Motion Sickness, Pregnancy, Others, etc.
Regional and Country-level Analysis
The Nausea And Vomiting Treatment market is analysed and market size information is provided by regions (countries).
The key regions covered in the Nausea And Vomiting Treatment market report are North America, Europe, China and Japan, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.

Competitive Landscape

and Nausea And Vomiting Treatment Market Share Analysis
Nausea And Vomiting Treatment market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Nausea And Vomiting Treatment business, the date to enter into the Nausea And Vomiting Treatment market, Nausea And Vomiting Treatment product introduction, recent developments, etc.
The major vendors include Merck & Co. Inc., Helsinn Group, Unimed Pharmaceuticals (AbbVie Inc.), Kyowa Kirin, Sanofi, Qilu Pharma, Teva Pharmaceutical Industries Ltd., Taiji group, Novartis, Heron Therapeutics, Atnahs Pharma UK Limited, Mylan, Duchesnay, Tesaro, etc.

This report focuses on the global Nausea And Vomiting Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Nausea And Vomiting Treatment development in North America, Europe, China and Japan.

The key players covered in this study

Merck & Co. Inc.
Helsinn Group
Unimed Pharmaceuticals (AbbVie Inc.)
Kyowa Kirin
Sanofi
Qilu Pharma
Teva Pharmaceutical Industries Ltd.
Taiji group
Novartis
Heron Therapeutics
Atnahs Pharma UK Limited
Mylan
Duchesnay
Tesaro

Market segment by Type, the product can be split into

Serotonin Receptor Antagonist
Neurokinin NK1 Receptor Antagonist
Other
Serotonin receptor antagonist had the biggest market share of 61% in 2018.

Market segment by Application, split into

CINV
PONV
Motion Sickness
Pregnancy
Others
CINV is the greatest segment of Nausea And Vomiting Treatment application, with a share of 49% in 2018.

Market segment by Regions/Countries, this report covers

North America
Europe
China
Japan

The study objectives of this report are:

To analyze global Nausea And Vomiting Treatment status, future forecast, growth opportunity, key market and key players.
To present the Nausea And Vomiting Treatment development in North America, Europe, China and Japan.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Nausea And Vomiting Treatment are as follows:
History Year: 2015-2019

Base Year:

2019

Estimated Year:

2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.